Cargando…

Production, purification, and radiolabeling of the (203)Pb/(212)Pb theranostic pair

BACKGROUND: Lead-212 ((212)Pb, t(1/2) = 10.6 h) and lead-203 ((203)Pb, t(1/2) = 51.9 h) are an element-equivalent, or a matched theranostic radioisotope pair that show great potential for application in targeted radionuclide therapy (TRT) and single-photon emission computed tomography (SPECT), respe...

Descripción completa

Detalles Bibliográficos
Autores principales:	McNeil, Brooke L., Robertson, Andrew K. H., Fu, Winnie, Yang, Hua, Hoehr, Cornelia, Ramogida, Caterina F., Schaffer, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851237/ https://www.ncbi.nlm.nih.gov/pubmed/33527221 http://dx.doi.org/10.1186/s41181-021-00121-4

Ejemplares similares

Optimized production, purification, and radiolabeling of the (203)Pb/(212)Pb theranostic pair for nuclear medicine
por: McNeil, Brooke L., et al.
Publicado: (2023)

A Theranostic Approach to Imaging and Treating Melanoma with (203)Pb/(212)Pb-Labeled Antibody Targeting Melanin
por: Jiao, Rubin, et al.
Publicado: (2023)

Preclinical Evaluation of a Lead Specific Chelator (PSC) Conjugated to Radiopeptides for (203)Pb and (212)Pb-Based Theranostics
por: Li, Mengshi, et al.
Publicado: (2023)

Development and dosimetry of (203)Pb/(212)Pb-labelled PSMA ligands: bringing “the lead” into PSMA-targeted alpha therapy?
por: dos Santos, José Carlos, et al.
Publicado: (2019)

Synthesis of DOTA-pyridine chelates for (64)Cu coordination and radiolabeling of αMSH peptide
por: Yang, Hua, et al.
Publicado: (2021)

Search of ligands suitable for (212)Pb/(212)Bi in vivo generators
por: Bartoś, Barbara, et al.
Publicado: (2012)

Influence of the Molar Activity of (203/212)Pb-PSC-PEG(2)-TOC on Somatostatin Receptor Type 2-Binding and Cell Uptake
por: Pretze, Marc, et al.
Publicado: (2023)

Implications of physics, chemistry and biology for dosimetry calculations using theranostic pairs
por: Miller, Cassandra, et al.
Publicado: (2022)

Development of a multi faceted platform containing a tetrazine, fluorophore and chelator: synthesis, characterization, radiolabeling, and immuno-SPECT imaging
por: McDonagh, Anthony W., et al.
Publicado: (2022)

(212)Pb: Production Approaches and Targeted Therapy Applications
por: Kokov, Konstantin V., et al.
Publicado: (2022)

Imaging of (212)Pb in mice with a clinical SPECT/CT
por: Kvassheim, Monika, et al.
Publicado: (2023)

Radiolabeled theranostics: magnetic and gold nanoparticles
por: Same, Saeideh, et al.
Publicado: (2016)

Radiolabelled Aptamers for Theranostic Treatment of Cancer
por: Khalid, Umair, et al.
Publicado: (2018)

[(212)Pb]Pb-eSOMA-01: A Promising Radioligand for Targeted Alpha Therapy of Neuroendocrine Tumors
por: Chapeau, Dylan, et al.
Publicado: (2023)

An Experimental Generator for Production of High-Purity (212)Pb for Use in Radiopharmaceuticals
por: Li, Ruth Gong, et al.
Publicado: (2023)

(203)Pb-VMT-α-NET Scintigraphy of a Patient With Neuroendocrine Tumor
por: Müller, Dirk, et al.
Publicado: (2023)

Factors Influencing the Therapeutic Efficacy of the PSMA Targeting Radioligand (212)Pb-NG001
por: Stenberg, Vilde Yuli, et al.
Publicado: (2022)

CD46 targeted (212)Pb alpha particle radioimmunotherapy for prostate cancer treatment
por: Li, Jun, et al.
Publicado: (2023)

Measurement of Direct Photons in pp and Pb–Pb Collisions with Conversion Pairs
por: Wilde, Martin
Publicado: (2016)

Toxicological Studies of (212)Pb Intravenously or Intraperitoneally Injected into Mice for a Phase 1 Trial
por: Milenic, Diane E., et al.
Publicado: (2015)

Safety and Outcome Measures of First-in-Human Intraperitoneal α Radioimmunotherapy With (212)Pb-TCMC-Trastuzumab
por: Meredith, Ruby F., et al.
Publicado: (2018)

(212)Pb α-Radioimmunotherapy Targeting CD38 in Multiple Myeloma: A Preclinical Study
por: Quelven, Isabelle, et al.
Publicado: (2020)

Optimized SPECT Imaging of (224)Ra α-Particle Therapy by (212)Pb Photon Emissions
por: Mikalsen, Lars Tore Gyland, et al.
Publicado: (2023)

Radiolabeled nanobodies as theranostic tools in targeted radionuclide therapy of cancer
por: D’Huyvetter, Matthias, et al.
Publicado: (2014)

Radiolabelled Cyclic Bisarylmercury: High Chemical and in vivo Stability for Theranostics
por: Gilpin, Ian Moore F., et al.
Publicado: (2021)

Study of Muon Pairs and Vector Mesons Produced in High Energy Pb-Pb Interactions
por: Ramos, S E, et al.
Publicado: (2002)

Study of muon pairs and vector mesons produced in high energy Pb-Pb interactions
por: CERN. Geneva. SPS Experiments Committee
Publicado: (1989)

Exclusive Photoproduction of $\Upsilon$ and lepton pairs in Pb-Pb at 5.5 TeV
por: d'Enterria, D, et al.
Publicado: (2008)

(212)Pb-radioimmunotherapy potentiates paclitaxel-induced cell killing efficacy by perturbing the mitotic spindle checkpoint
por: Yong, K J, et al.
Publicado: (2013)

Transverse momentum balance of b-jet pairs in PbPb collisions at 5 TeV
por: CMS Collaboration
Publicado: (2016)

Transverse momentum balance of b-jet pairs in PbPb collisions with the CMS experiment at the LHC
por: Lisniak, Stanislav
Publicado: (2020)

Proposal: study of muon pairs and vector mesons produced in high energy Pb-Pb interactions
por: Abreu, M C, et al.
Publicado: (1991)

Intermediate mass muon pair continuum in Pb-Pb collisions at 158 GeV/c
por: Abreu, M C, et al.
Publicado: (1996)

Production, Purification, and Applications of a Potential Theranostic Pair: Cobalt-55 and Cobalt-58m
por: Barrett, Kendall E., et al.
Publicado: (2021)

Advances in GLP-1 receptor targeting radiolabeled agent development and prospective of theranostics
por: Velikyan, Irina, et al.
Publicado: (2020)

Covalent core-radiolabeling of polymeric micelles with (125)I/(211)At for theranostic radiotherapy
por: Sporer, Emanuel, et al.
Publicado: (2022)

Development of (225)Ac Radiopharmaceuticals: TRIUMF Perspectives and Experiences
por: Robertson, Andrew Kyle Henderson, et al.
Publicado: (2018)

Bottomonia in pp, pPb and PbPb
por: Filipovic, Nicolas
Publicado: (2015)

PB2653: SYNTHESIS OF MAGNETIC NANOPARTICLES SUITABLE FOR PURIFICATION FACTOR VIII
por: Shurko, Nataliya, et al.
Publicado: (2023)

Gene expression profiling upon (212)Pb-TCMC-trastuzumab treatment in the LS-174T i.p. xenograft model
por: Yong, Kwon J, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_p900pp2d672vlmsjsutdsi90u3